Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026)
Bicycle Therapeutics' (BCYC) quarterly Other Non Operating Income came in at $69000.0 in Q2 2026, down 90.74% YoY from $745000.0 in Q2 2025, and down 35.51% on a QoQ basis from $107000.0 in Q1 2026.
Analysis
Bicycle Therapeutics (BCYC) Other Non Operating Income (2018 - 2026) Analysis & Trends
Bicycle Therapeutics (BCYC) has 5 years of Other Non Operating Income data on file, last reported at $69000.0 in Q2 2026.
- Quarterly Other Non Operating Income fell 90.74% year-over-year to $69000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.5 million (up 3078.63% YoY) and the FY2025 annual result came in at $13.9 million, up 1489.3% from the prior year.
- Other Non Operating Income slipped to $69000.0 in Q2 2026, from $107000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $13.2 million in Q4 2025 to a low of -$1.0 million in Q3 2024.
- A 3-year average of $1.5 million and a median of $101000.0 in 2024 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 637.62% in 2025, down 380.28% in 2025.
- Tracing BCYC's Other Non Operating Income over 3 years: stood at -$1.0 million in 2024, then surged by 1418.9% to $13.2 million in 2025, then slumped by 99.48% to $69000.0 in 2026.
- The last three Other Non Operating Income figures came in at $69000.0 (Q2 2026), $107000.0 (Q1 2026), and $13.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Bicycle Therapeutics | 299.11 Mn | 299.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69,000.00 |
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 13.19 Mn |
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 745,000.00 |
| Mar 31, 2025 | -199,000.00 |
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | 101,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Jun 30, 2019 | -2.18 Mn |
| Mar 31, 2019 | -3.19 Mn |
| Dec 31, 2018 | 807,000.00 |
| Sep 30, 2018 | -1.36 Mn |
| Jun 30, 2018 | -73,000.00 |